RxDoctor Payments DataLook up a doctor →

Mark Brody

Neurology · Delray Beach, FLNPI 1962519538

Payments from drug & device makers

$20,499,878in general payments, 2019–2025

Across 621 payments — averaging $33,011 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$8.6M
  • Biogen$6.1M
  • Eisai Inc.$2.4M
  • Genentech, Inc.$1.9M
  • Novartis$699K
  • F. Hoffmann-la Roche AG$285K
  • plus $492K from 10 others
$38,621in research payments, 2019–2025

Across 17 payments — averaging $2271.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$36K
  • Novo Nordisk$2K
  • Novo Nordisk AS$48

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$20,499,878 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida

Other neurology in Delray Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →